Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Hron

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis Research|January 29, 2013
Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopeniaKarina Althaus, Gregor Hron, Ulrike Strobel, et al.
Archives of Internal Medicine|August 13, 2008
Overweight, obesity, and the risk of recurrent venous thromboembolismSabine Eichinger, Gregor Hron, Christine Bialonczyk, et al.
Circulation|March 21, 2007
High-density lipoprotein and the risk of recurrent venous thromboembolismSabine Eichinger, Natalie M Pecheniuk, Gregor Hron, et al.
Blood Transfusion = Trasfusione Del Sangue|July 21, 2015
Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivationThomas Thiele, Gregor Hron, Sarah Kellner, et al.
Archives of Internal Medicine|August 16, 2006
Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolismBernd Jilma, Florian M Kovar, Gregor Hron, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2006
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolismDominik G Haider, Robert A Bucek, Markus Reiter, et al.
The American Journal of Medicine|January 25, 2006
Family history for venous thromboembolism and the risk for recurrenceGregor Hron, Sabine Eichinger, Ansgar Weltermann, et al.
Transfusion|September 2, 2011
Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivationThomas Thiele, Sarah Kellner, Gregor Hron, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel diseaseJulia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis Research|January 29, 2013
Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopeniaKarina Althaus, Gregor Hron, Ulrike Strobel, et al.
Archives of Internal Medicine|August 13, 2008
Overweight, obesity, and the risk of recurrent venous thromboembolismSabine Eichinger, Gregor Hron, Christine Bialonczyk, et al.
Circulation|March 21, 2007
High-density lipoprotein and the risk of recurrent venous thromboembolismSabine Eichinger, Natalie M Pecheniuk, Gregor Hron, et al.
Blood Transfusion = Trasfusione Del Sangue|July 21, 2015
Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivationThomas Thiele, Gregor Hron, Sarah Kellner, et al.
Archives of Internal Medicine|August 16, 2006
Homozygosity in the single nucleotide polymorphism Ser128Arg in the E-selectin gene associated with recurrent venous thromboembolismBernd Jilma, Florian M Kovar, Gregor Hron, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2006
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolismDominik G Haider, Robert A Bucek, Markus Reiter, et al.
The American Journal of Medicine|January 25, 2006
Family history for venous thromboembolism and the risk for recurrenceGregor Hron, Sabine Eichinger, Ansgar Weltermann, et al.
Transfusion|September 2, 2011
Storage of thawed plasma for a liquid plasma bank: impact of temperature and methylene blue pathogen inactivationThomas Thiele, Sarah Kellner, Gregor Hron, et al.
Journal of Crohn'S & Colitis|June 19, 2012
Tissue factor exposing microparticles in inflammatory bowel diseaseJulia Palkovits, Gottfried Novacek, Marietta Kollars, et al.
Pageof 3